MedPath

A randomized controlled study on the treatment of androgen alopecia caused by spleen deficiency and dampness in combination with Qushi Jianfa Decoction for internal administration.

Early Phase 1
Conditions
Androgenic alopecia
Registration Number
ITMCTR2024000172
Lead Sponsor
Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Age 18-50 years old (including 18 and 50 years old) is not limited to men and women
2) Meet the AGA diagnostic criteria and syndrome diagnosis criteria of Chinese Androgenic Alopecia Diagnosis and Treatment Guide;
3) The severity of hair loss: in line with the Hamilton scale of IIa-III stage;
4) Agree to present the hair of the observation site and temporarily dye the spot hair;
5) Voluntarily participate in this study, can adhere to medication and follow-up, and sign informed consent.

Exclusion Criteria

1) Serious heart, liver, kidney, mental diseases and other skin diseases;
2) Received systemic treatment and local treatment for hair loss within 3 months;
3) Abnormal results of laboratory tests (blood routine, urine routine, liver and kidney function) during the screening period and judged by doctors to be clinically significant;
4) Those who do not agree to maintain hair style and hair color during the test;
5) had previously undergone hair transplant surgery, scalp reconstruction, or scalp tattooing;
6) Use or have used hair removal drugs, laser hair removal, use wax on the scalp;
7) Scalp with seborrheic dermatitis, bald folliculitis, alopecia areata;
8) Diseases that researchers believe may affect hair growth, such as immune deficiency, connective tissue-related diseases, or infectious alopecia;
9) Patients with small scalp and hair color contrast, such as too light skin or too white hair;
10) For other conditions that the investigator deems inappropriate to participate in the clinical trial.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scalp oil;Hair number;
Secondary Outcome Measures
NameTimeMethod
Scalp itch degree;Hair diameter;Hair folliculitis of the scalp;Dandruff condition;
© Copyright 2025. All Rights Reserved by MedPath